- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Nov 19, 2014
Highlights
- Market Cap
- $110.38M
- Enterprise Value
- $110.69M
- EPS (TTM)
- -$0.40
- Gross Profit (TTM)
- -$220.00K
- EBITDA (TTM)
- -$27.38M
- Year Range
- $0.92 - $1.92
- ROA (TTM)
- -63.96%
- ROE (TTM)
- -141.93%
- Avg. Volume (1M)
- 1M
- Avg. Volume Value (1M)
- $1.43M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
VANI Performance Chart
Vivani Medical Inc. (VANI) is up 4.1% since the beginning of the year. At $1 per share, VANI is trading 33.3% below its 52-week high of $2. Investors who bought $1,000 worth of VANI shares 5 years ago would now be looking at an investment worth $112.
Loading charts...
Compare this symbol against anything
Returns By Period
Vivani Medical Inc. (VANI) has returned 4.07% so far this year and -3.76% over the past 12 months. Over the last ten years, VANI has returned -35.03% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Vivani Medical Inc.
- 1D
- -1.54%
- 1M
- 1.59%
- 6M
- -7.91%
- YTD
- 4.07%
- 1Y
- -3.76%
- 3Y*
- 0.79%
- 5Y*
- -35.49%
- 10Y*
- -35.03%
- ALL TIME*
- -38.91%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
VANI Monthly Returns History
Based on dividend-adjusted daily data since Nov 19, 2014, VANI's average daily return is +0.08%, while the average monthly return is +1.42%. At this rate, an investment would double in approximately 4.1 years.
Historically, 39% of months were positive and 61% were negative. The best month was Mar 2021 with a return of +374.1%, while the worst month was Mar 2020 at -76.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 7 months.
On a daily basis, VANI closed higher 41% of trading days. The best single day was Mar 5, 2021 with a return of +304.9%, while the worst single day was Mar 30, 2020 at -51.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 13.01% | -11.51% | -18.70% | 34.00% | -1.49% | -6.06% | 3.23% | 4.07% | |||||
| 2025 | 2.59% | -6.72% | -5.41% | -1.90% | 22.33% | 2.38% | 3.88% | -14.18% | 22.61% | 14.18% | -15.53% | -9.56% | 6.03% |
| 2024 | -0.98% | 317.82% | -56.16% | -12.43% | 0.62% | -22.70% | -2.38% | 6.50% | -10.69% | 11.97% | 9.92% | -19.44% | 13.73% |
| 2023 | 41.23% | -8.33% | -9.09% | 11.00% | 18.02% | -7.63% | 4.13% | -26.58% | 10.26% | 1.96% | -8.65% | 7.37% | 20.04% |
| 2022 | -14.11% | -6.43% | 9.16% | 3.50% | 58.78% | -13.62% | -11.33% | -23.33% | -44.93% | -20.61% | -22.65% | -39.31% | -82.62% |
| 2021 | 15.51% | -19.44% | 374.14% | -16.48% | -13.21% | -17.39% | -22.67% | 1.05% | -17.36% | -14.11% | -27.74% | -17.68% | -12.83% |
Benchmark Metrics
Vivani Medical Inc. has an annualized alpha of 8.94%, beta of 0.99, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since November 19, 2014.
- This stock participated in 247.06% of S&P 500 Index downside but only 75.70% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 8.94%
- Beta
- 0.99
- R²
- 0.01
- Upside Capture
- 75.70%
- Downside Capture
- 247.06%
Return for Risk
Risk / Return Rank
VANI ranks 43 for risk / return — above 43% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Vivani Medical Inc. (VANI) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VANI | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.48 | ||
| Sortino ratioReturn per unit of downside risk | -1.50 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.25 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.09 | 2.00 | -2.09 |
| Martin ratioReturn relative to average drawdown | -0.16 | 8.49 | -8.65 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Vivani Medical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Vivani Medical Inc. was 99.85%, occurring on Dec 30, 2022. The portfolio has not yet recovered.
The current Vivani Medical Inc. drawdown is 99.77%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.85%Dec 2022 | 8y 1mo | — | 11y 8moNov 2014 - now | Bear market2022 |
Drawdown Indicators
| VANI | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.85% | -56.78% | -43.07% |
Max Drawdown (1Y)Largest decline over 1 year | -49.84% | -9.10% | -40.74% |
Max Drawdown (3Y)Largest decline over 3 years | -77.77% | -18.90% | -58.87% |
Max Drawdown (5Y)Largest decline over 5 years | -92.81% | -25.43% | -67.38% |
Max Drawdown (10Y)Largest decline over 10 years | -99.15% | -33.92% | -65.23% |
Current DrawdownCurrent decline from peak | -99.77% | -1.58% | -98.19% |
Average DrawdownAverage peak-to-trough decline | -92.35% | -10.70% | -81.65% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.51% | 2.14% | +26.37% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Vivani Medical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Vivani Medical Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for VANI in comparison with other companies in the Biotechnology industry. Currently, VANI has a P/B value of 5.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with VANI
Add Vivani Medical Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with VANI